I E van der Horst-Bruinsma
Overview
Explore the profile of I E van der Horst-Bruinsma including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
65
Citations
1602
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Ornbjerg L, Brahe C, Linde L, Jacobsson L, Nissen M, Kristianslund E, et al.
Joint Bone Spine
. 2024 Apr;
91(4):105729.
PMID: 38582359
Objective: To investigate real-world retention and remission rates in PsA patients initiating a 2nd or 3rd TNFi and the association with reason for discontinuation from the previous TNFi-treatment. Methods: Prospectively...
2.
Swart I, Visman I, Heslinga M, van der Horst-Bruinsma I, van Denderen J, Nurmohamed M
Clin Rheumatol
. 2022 Aug;
41(12):3747-3752.
PMID: 35962246
Background: Biologicals, such as anti-tumor necrosis factor (anti-TNF), reduce cardiovascular disease (CVD) in patients with inflammatory rheumatic diseases. Impaired renal function is a known predictor of CVD and elevated in...
3.
Rusman T, van der Weijden M, Nurmohamed M, van Denderen C, Landewe R, Bet P, et al.
Scand J Rheumatol
. 2022 May;
52(2):137-141.
PMID: 35543102
Objective: To study the long-term effect of 16 weeks of etanercept treatment on disease activity and radiographic changes in patients with suspected non-radiographic axial spondyloarthritis (nr-axSpA). Method: Eighty patients with...
4.
Baniaamam M, Heslinga S, Konings T, Handoko M, Kamp O, van Halm V, et al.
Rheumatol Int
. 2021 Nov;
42(4):683-688.
PMID: 34729637
To assess the association between the aortic root diameter in HLA-B27 positive (+) and HLA-B27 negative (-) ankylosing spondylitis (AS) patients from the CARDAS cohort. The CARDAS study is a...
5.
Rusman T, Nurmohamed M, Hoekstra S, van Denderen C, van Vollenhoven R, Boers M, et al.
Scand J Rheumatol
. 2021 Nov;
51(6):506-512.
PMID: 34726125
Objective: To assess sex differences in response, level of disease activity, and drug survival in tumour necrosis factor inhibitor (TNFi)-naïve ankylosing spondylitis (AS) patients. Method: Consecutive AS patients, fulfilling the...
6.
van Bentum R, Baniaamam M, Kinaci-Tas B, van de Kreeke J, Kocyigit M, Tomassen J, et al.
Semin Arthritis Rheum
. 2020 Sep;
50(6):1535-1541.
PMID: 32967777
Objective: Ankylosing spondylitis (AS) is associated with an increased risk of cardiovascular disease (CVD). Microvasculature changes can precede overt CVD, but have been studied poorly in AS. The retinal vasculature...
7.
van den Oever I, Baniaamam M, Simsek S, Raterman H, van Denderen J, van Eijk I, et al.
Rheumatol Int
. 2020 Aug;
41(2):319-328.
PMID: 32776224
Given the link between systemic inflammation, body composition and insulin resistance (IR), anti-inflammatory therapy may improve IR and body composition in inflammatory joint diseases. This study assesses the IR and...
8.
Michelsen B, Ornbjerg L, Kvien T, Pavelka K, Nissen M, Nordstrom D, et al.
Rheumatology (Oxford)
. 2020 Jan;
59(9):2455-2461.
PMID: 31960053
Objectives: To assess the impact of 'patient's minus evaluator's global assessment of disease activity' (ΔPEG) at treatment initiation on retention and remission rates of TNF inhibitors (TNFi) in psoriatic arthritis...
9.
Brahe C, Ornbjerg L, Jacobsson L, Nissen M, Kristianslund E, Mann H, et al.
Rheumatology (Oxford)
. 2019 Oct;
59(7):1640-1650.
PMID: 31665497
Objective: To investigate TNF inhibitor (TNFi) retention and response rates in European biologic-naïve patients with PsA. Methods: Prospectively collected data on PsA patients in routine care from 12 European registries...
10.
Heslinga S, Konings T, van der Horst-Bruinsma I, Kamp O, van Halm V, de Bruin-Bon H, et al.
Biologics
. 2018 Dec;
12:143-149.
PMID: 30510398
Background: Diastolic left ventricular (LV) dysfunction appears more prevalent in ankylosing spondylitis (AS). The effects of tumor necrosis factor alpha (TNF-α) blocking therapy, a strong and effective anti-inflammatory drug, on...